Warszawski Szpital Okulistyczny Sp. z o.o.

At Warszawski Szpital Okulistyczny Sp. z o.o., clinical research in eye diseases includes studies focused on diabetic retinopathy and diabetic macular edema. These trials are designed to better understand disease progression and assess new treatment options that may help preserve vision in people affected by diabetes-related eye damage.

• Diabetic retinopathy
• Centre-involved diabetic macular edema
• Diabetic Macular Edema (DME)

The main goal is to evaluate how well emerging therapies can improve retinal health, reduce vision loss, and support more effective care for patients with diabetic eye complications.

Another major area of work is age-related macular degeneration, including both wet AMD and dry AMD with geographic atrophy. Research at this site examines new approaches intended to slow vision decline, improve visual function, and compare investigational treatments with established therapies.

• Exudative age-related macular degeneration
• Neovascular age-related macular degeneration (nAMD)
• Wet age-related macular degeneration (wAMD)
• Dry Age-Related Macular Degeneration (AMD) with geographic atrophy (GA)
• Geographic Atrophy

These studies aim to test treatment effectiveness for retinal degeneration and vision-threatening macular disease, helping refine care for people living with progressive macular disorders.

The site also participates in trials on thyroid eye disease, a condition that can cause inflammation, discomfort, and changes in eye appearance and function. Research here is centered on evaluating whether new therapies can reduce symptoms, improve tolerability, and offer longer-term disease control.

• Thyroid eye disease

These studies are helping to clarify the role of novel treatments for both active and chronic forms of the disease, with a focus on symptom relief and overall patient benefit.

Clinical trials at this hospital include research in non-infectious uveitis, covering intermediate uveitis, posterior uveitis, and panuveitis. The studies are intended to assess new therapies that may better control inflammation and protect vision in people with chronic ocular inflammatory disease.

• active non-infectious uveitis (intermediate uveitis, posterior uveitis, panuveitis)

This line of research supports the search for safer and more effective treatment options for patients whose eye inflammation can lead to lasting visual impairment.

Research at Warszawski Szpital Okulistyczny Sp. z o.o. also extends to myopia in children. These studies are exploring whether new ophthalmic treatments can help slow the progression of nearsightedness and reduce the risk of future vision problems.

• myopia

The purpose is to improve long-term eye health in pediatric patients by evaluating approaches that may better manage the advancement of refractive disease.